Greenbrook TMS (Greenbrook TMS) Momentum Rank : 0 (As of May. 23, 2024)

View and export this data going back to 2018. Start your Free Trial

What is Greenbrook TMS Momentum Rank?

Greenbrook TMS has the Momentum Rank of 0.

For Momentum Rank, we considered the residual momentum concept that was widely studied by Blitz and his colleagues as well as by Nobel Prize laureates Fama and French. However, we did not find any significant differences in the performances of stocks with different ranks of residual momentum. Therefore, we use traditional momentum instead.

Momentum Rank is determined using the standardized momentum ratio and other momentum indicators. The standardized momentum ratio is the average of the performances from 12 months ago to 1 month ago and 6 months ago to 1 month ago, divided by the beta of the stock over the past 12 months. To calculate the momentum ratio today, we would use the average of the two performance numbers.

For momentum, we found that stock price performance does not have a monotonic correlation with the momentum ratio. The stocks with the highest momentum ratios perform worse than those at about the 70th percentile. Therefore, for the momentum rank, we ranked the stocks at about the 70th percentile of the momentum ratio as the highest at 10.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

Greenbrook TMS Momentum Rank Related Terms

Thank you for viewing the detailed overview of Greenbrook TMS's Momentum Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Greenbrook TMS (Greenbrook TMS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Greenbrook TMS Inc (OTCPK:GBNHF) » Definitions » Momentum Rank

Comparable Companies

Traded in Other Exchanges

N/A

Address

890 Yonge Street, 7th Floor, Toronto, ON, CAN, M4W 3P4

Website

https://www.greenbrooktms.com

Greenbrook TMS Inc is a provider of Transcranial Magnetic Stimulation (TMS) therapy, an FDA-cleared, non-invasive therapy for the treatment of major depressive disorder and other mental health disorders, in the United States. TMS therapy provides local electromagnetic stimulation to specific brain regions known to be directly associated with mood regulation. Greenbrook has provided over 11,00,000 TMS treatments to over 31,000 patients struggling with depression.